Skip to main content
KLOW Source

The material, the tissue and the experiment around a peptide result.

KLOW peptide references

Wound dressings, gut cells, injured tendons and the wider component literature.

Experimental surroundingsAbout KLOW Source

Experimental materials

The GHK hydrogel study brings the delivery material into the foreground. For another kind of modification, the KPV glycoalkylation paper concerns chemical characterization. The palmitoyl copper peptide and acetyl tyrosine experiment concerns pigmentation in human and mouse melanoma cell lines.

Repair and inflammatory signaling

The rat Achilles tendon paper, PepT1 and KPV paper and full-length thymosin beta-4 wound paper are the main individual experimental landmarks. The rodent liver-fibrosis study adds another tissue setting for thymosin beta-4.

Reviews and human safety

The 2015 GHK skin review and 2018 gene-data review cover different parts of the copper-peptide record. The BPC-157 neurotransmitter review and cytoprotection review bring together broad preclinical claims. The small intravenous BPC-157 pilot and musculoskeletal safety review address very different human-safety questions. Full citations follow.

  1. Malinda KM, et al. Thymosin beta4 accelerates wound healing. J Invest Dermatol. 1999;113(3):364-368. ↗
  2. Staresinic M, et al. Gastric pentadecapeptide BPC 157 accelerates healing of transected rat Achilles tendon and in vitro stimulates tendocytes growth. J Orthop Res. 2003;21(6):976-983. ↗
  3. Dalmasso G, Charrier-Hisamuddin L, Nguyen HT, Yan Y, Sitaraman S, Merlin D. PepT1-mediated tripeptide KPV uptake reduces intestinal inflammation. Gastroenterology. 2008;134(1):166-178. ↗
  4. Pickart L, Vasquez-Soltero JM, Margolina A. GHK Peptide as a Natural Modulator of Multiple Cellular Pathways in Skin Regeneration. BioMed Research International. 2015;2015:648108. ↗
  5. Pickart L, Margolina A. Regenerative and Protective Actions of the GHK-Cu Peptide in the Light of the New Gene Data. International Journal of Molecular Sciences. 2018;19(7):1987. ↗
  6. Lee E, Burgess K. Safety of Intravenous Infusion of BPC157 in Humans: A Pilot Study. Altern Ther Health Med. 2025;31(5):20-24. ↗
  7. Mendias CL, Awan TM. Safety and Efficacy of Approved and Unapproved Peptide Therapies for Musculoskeletal Injuries and Athletic Performance. Sports Med. 2026. ↗
  8. Dettin M, et al. Structural modification of the tripeptide KPV by reductive glycoalkylation of the lysine residue. PLoS One. 2018;13(6):e0199686. ↗
  9. Zhu J, et al. Mechanism of thymosin β4 in ameliorating liver fibrosis via the MAPK/NF-κB signaling pathway. J Biochem Mol Toxicol. 2023. ↗
  10. Lee S, Lee SM, Lee SH, Choi WK, Park SJ, Kim DY, et al. In situ photo-crosslinkable hyaluronic acid-based hydrogel embedded with GHK peptide nanofibers for bioactive wound healing. Acta Biomaterialia. 2023. ↗
  11. Sikiric P, et al. The Stable Gastric Pentadecapeptide BPC 157 Pleiotropic Beneficial Activity and Its Possible Relations with Neurotransmitter Activity. Pharmaceuticals (Basel). 2024;17(4):461. ↗
  12. Author group. Concerning BPC-157, a natural pentadecapeptide, that acts as a cytoprotectant. Inflammopharmacology. 2025. ↗
  13. Hong M, Gui Y, Xu J, Zhao X, Jiang C, Zhao J, Xin X, Liu D, Tang X, Tang R, An F. Palmitoyl copper peptide and acetyl tyrosine complex enhances melanin production in both A375 and B16 cell lines. Biochemical and Biophysical Research Communications. 2025. ↗